Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: An experimental immunomodulatory therapy

被引：52

作者：

Abad, C ^{[1
]}

Martinez, C ^{[1
]}

Leceta, J ^{[1
]}

Gomariz, RP ^{[1
]}

Delgado, M ^{[1
]}

机构：

[1] Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain

来源：

JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 06期

关键词：

D O I：

10.4049/jimmunol.167.6.3182

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Rheumatoid arthritis is a chronic, systemic, autoimmune, and inflammatory disorder that affects the synovial lining of the joints. We describe the beneficial effects of the pituitary adenylate cyclase-activating polypeptide (PACAP) in the collagen-induced arthritis experimental murine model being proposed as a novel therapeutic approach in the treatment of rheumatoid arthritis. PACAP greatly decreases arthritis frequency and severity in the studied mice by improving clinical symptoms, ameliorating joint damage, and blocking both the inflammatory and autoimmune mediators which are the main keys of the pathogenesis of this disease. With this study, PACAP emerges as a promising candidate for the treatment of a pathology with a high world incidence but currently no effective treatment.

引用

页码：3182 / 3189

页数：8

共 46 条

[1]

ARIMURA A, 1992, REGUL PEPTIDES, V37, P287

[2]

Butler DM, 1997, J IMMUNOL, V159, P2867

[3]

Charles P, 1999, J IMMUNOL, V163, P1521

[4] Established rheumatoid arthritis [J].

Conaghan, PG ;

Green, MJ ;

Emery, P .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 1999, 13 (04) :561-575

[5]

Cunnane Gaye, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P1

[6] Phosphodiesterase 4 inhibitors, structurally unrelated to Rolipram, as promising agents for the treatment of asthma and other pathologies [J].

Dal Piaz, V ;

Giovannoni, MP .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (05) :463-480

[7] VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines [J].

Delgado, M ;

Munoz-Elias, EJ ;

Martinez, C ;

Gomariz, RP ;

Ganea, D .

NEUROPEPTIDES: STRUCTURE AND FUNCTION IN BIOLOGY AND BEHAVIOR, 1999, 897 :401-414

[8] Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor α transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun [J].

Delgado, M ;

Munoz-Elias, EJ ;

Kan, YQ ;

Gozes, I ;

Fridkin, M ;

Brenneman, DE ;

Gomariz, RP ;

Ganea, D .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (47) :31427-31436

[9]

Delgado M, 1999, J IMMUNOL, V162, P4685

[10]

Delgado M, 1999, J IMMUNOL, V162, P2358

← 1 2 3 4 5 →